ConCallIQ
Go Pro
EKC Diversified 15 Nov 2025

Everest Kanto Cylinder Limited — Q2 FY26

Everest Kanto Cylinder reported Q2 FY26 consolidated revenue of ₹360 crore and EBITDA of ₹42.9 crore (11.9% margin).

neutral medium
Compare with...
Revenue ₹360 Cr
EBITDA ₹43 Cr
PAT ₹14 Cr
EBITDA Margin 12%
Duration 30 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Everest Kanto Cylinder reported Q2 FY26 consolidated revenue of ₹360 crore and EBITDA of ₹42.9 crore (11.9% margin). PAT stood at ₹13.7 crore. The CNG segment faced temporary softness due to BS6 transition in the automotive industry, which has since normalized. Industrial segment performed in line. The US business saw lower dispatches due to order-driven nature. Management guided EBITDA margins of 12-14% for the full year. Expansion at Mundra (₹130 crore spent, ₹30 crore balance) and Egypt (₹86 crore spent, ₹40 crore balance) is on track, with Egypt trial production expected by January 2026 and Mundra by March 2026. Combined order book is ₹1,000 crore executable over 12 months. Risks include GST litigation and potential forex penalty recurrence.

Promises0 met · 3 missedRisks3 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 3 promises

Promise Tracker

0 delivered, 0 close, 3 missed.

View Promises →
!Risks 3 risks

Risk Intelligence

GST litigation uncertainty

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Order Book (Combined) ₹1,000 crore
N/A

Total order book across all locations, executable over next 12 months.

US Order Book $80 million
N/A

Order book for US operations, execution timeline 12-18 months.

Standalone Capacity Utilization 70%
N/A

Current utilization rate for standalone business; potential to increase by 20%.

Egypt Plant Capex Spent ₹86 crore
N/A

Capital expenditure incurred on Egypt plant; balance ₹40 crore remains.

What Changed vs Last Quarter

Comparing Q2 FY26 vs Q1 FY26
3 new guidance3 dropped3 new risk3 risk resolved
NEW
EBITDA margin guidance of 12-14% for FY26

Management expects full-year EBITDA margins to be in the range of 12-14%.

NEW
Mundra plant commercialization by March 2026

The Mundra plant is expected to be commercialized by March 2026.

NEW
Revenue target of ₹900-2,000 crore for standalone

Management indicated a revenue target range for standalone business, though exact figure was unclear.

UPDATED
Egypt plant trial production by January 2026

The Egypt facility is expected to begin trial production by January 2026.

DROPPED
India business margins to sustain at 13-14%

Management expects India EBITDA margins to be in the range of 13-14% on a conservative basis, though they strive for higher.

DROPPED
India revenue growth of 10-15%

Management guided for 10-15% revenue growth in India business for FY26.

DROPPED
Mundra plant commercial production by Q4 FY26

The Mundra facility is expected to start commercial production just before the close of FY26.

NEW RISK
GST litigation uncertainty

The company has received GST demands and is awaiting government response; outcome and timeline are uncertain.

NEW RISK
Forex penalty recurrence

A ₹11 crore penalty was incurred for shortfall in net foreign exchange earnings; similar penalties may arise in future assessments.

NEW RISK
Margin pressure from product mix

Gross margins declined due to lower volumes in high-margin products; mix shift could continue to pressure margins.

RISK GONE
GST contingent liability of ₹352 crore

The company faces a GST dispute with a contingent liability of ₹352 crore, roughly 30% of net worth. Management is confident of a favorable outcome but hearing date is not yet fixed.

RISK GONE
UAE business headwinds

The UAE business is facing certain headwinds and is expected to remain moderate in the coming quarters.

RISK GONE
Margin sustainability in India

India margins improved sharply to 17.2% in Q1, but management guided for a more conservative 13-14% going forward, indicating the high margin may not be sustainable.

Fast read

Guidance and risk preview

Top guidance EBITDA margin guidance of 12-14% for FY26

Management expects full-year EBITDA margins to be in the range of 12-14%.

Top risk GST litigation uncertainty

The company has received GST demands and is awaiting government response; outcome and timeline are uncertain.

View Risks →